ArticleMolecular cancer therapeutics2014

Combination therapy for KIT-mutant mast cells: targeting constitutive NFAT and KIT activity.

Alison C Macleod et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.